Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04597957 · ClinicalTrials.gov registry record · Early Phase 1
The Fruit and Vegetable Prescription Program Study
A Early Phase 1 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 200
- Enrollment target
NCT04597957: Completed Early Phase 1 study, sponsored by Henry Ford Health System.
NCT04597957 is a Early Phase 1 study that has completed, run by Henry Ford Health System. The registered enrollment target is 200 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (277% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04597957, a Early Phase 1 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
The Fruit and Vegetable Prescription Program Study is a pilot randomized controlled trial of patients with type 2 diabetes participating in a fruit and vegetable prescription program from a Federally Qualified Health Center in Detroit, MI . Changes in hemoglobin A1C (%), blood pressure (BP) and weight (lbs.) will be assessed changes to discern the impact on those that participated in a fruit and vegetable prescription program compared to those that received non-incentivized diabetes standard of care.
Primary Outcome
Both intervention and control groups will have hemoglobin a1c (%) tested at initial visit and 3 months after initial visit.
Interventions
- DIETARY_SUPPLEMENT Fresh Rx Intervention group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2019-01-02 |
| Phase | Early Phase 1 |
What the finished NCT04597957 record still lists
NCT04597957 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (277% higher).
The record links to 0 conditions, and to 1 intervention - of which Fresh Rx Intervention group is the first listed.
NCT04597957 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04597957 about?
NCT04597957 is a clinical study titled "The Fruit and Vegetable Prescription Program Study". The Fruit and Vegetable Prescription Program Study is a pilot randomized controlled trial of patients with type 2 diabetes participating in a fruit and vegetable prescription program from a Federally Qualified Health Center in Detroit, MI . Changes in hemoglobin A1C (%), blood pressure (BP) and weig...
What is the current status of trial NCT04597957?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 200 participants. The study started on 2018-07-12. Estimated completion is 2019-01-02.
What interventions are being tested in trial NCT04597957?
The interventions under investigation include: Fresh Rx Intervention group (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04597957?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04597957's enrollment target sits among peer trials
200 60th of 2000 higher than 1,934 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI